ATRE

A3

Market Cap 558.6M
Today
Day High
17.90
17.9
Day Low
16.75
Day Open
17.00
Prev Close
17.90
VWAP
17.2
Volume
4K
Turnover
0.065M
Top Broker
AVA
VWAP
16.9
Avg Volume
5K
Avg Turnover
0.085M
Top Brokers
AVA/NON
VWAP
16.4
Avg Volume
7K
Avg Turnover
0.127M
Top Brokers
AVA/NON
VWAP
16.3
Avg Volume
10K
Avg Turnover
0.163M
Top Brokers
AVA/NON
52 week summary
Price Range
15.5
Last
26.4
Beta
N/A
Market Cap
558.6M
Total Return
-4.1%
Trailing P/E
40.0
Div Yield
7.1%
Shares Outstanding
32.9M
Stock Exchange
NASDAQ Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.

Relative Price Strength
Change 3 Months -12.8%
Change 12 Months -14.6%
Volume Trend
Average Volume 10 vs 60 Days -41.6%
Price VS
52 Week High -32.2%
50 Day Moving Average 3.8%
200 Day moving Average -5.0%

Add article markers

Compare A3 to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Johan Hellström, CEO
  • Annika Westberg, CFO
  • Executive board
  • Thomas Nygren, Chairman of the board
Last updated: 2017-05-30 Source: Redeye
Major Owners Equity Votes
Mark Hauschildt 46.8%
46.8%
On Top Of It AB 8.4%
8.4%
Wilderness Consulting Sweden AB 8.4%
8.4%
Sfö Holding Söder AB 5.1%
5.1%
Pemberton Holding Limited 4.0%
4.0%
Öhman Fonder 3.1%
3.1%
Ola Norberg 3.0%
3.0%
Hans Hellspong 2.4%
2.4%
Thomas Nygren 1.6%
1.6%
Stefan Häge 1.5%
1.5%
Last updated: 2018-01-11 Source: Redeye/Holdings
Timeframe Transactions Net Shares
Last 12 weeks
0 Purchases
0
1 Sales
-41,019
Last 24 weeks
0 Purchases
0
1 Sales
-41,019
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2015
  •  
  • -23.9%
  • -16.6%
  • -14.7%
  • 7.1%
  • -5.8%
  • -6.2%
  •  
  • -1.83
  • -1.83
  • 0.75
  •  
  • 26.7
  •  
  • 501.7
  • -8.8
  • -9.2
  • 0.5
  • 0.6
  • 9.0
  • -11.0
  • 2.6
  •  
  • 37.9%
  • 13.4%
  • 66
  • 233
  • 1.8
  • 2015
  •  
  •  
  • 0
  • 87
  • 4
  • 55
  • 145
  •  
  • 13
  • 0
  • 18
  • 70
  • 0
  • 185
  • 0
  • 285
  • 10
  • 441
  •  
  •  
  • 40
  • 106
  • 102
  • 247
  • 26
  • 0
  • 0
  • 274
  • 0
  • 0
  • 164
  • 3
  • 167
  • 440
  • 2015
  • 783
  • -727
  • -102
  • -46
  • -3
  • -45
  • 102
  • 57
  • -8
  • -20
  • 26
  • 2015 Q1
  • 206
  • -191
  • 15
  • -11
  • 0
  • 0
  • 4
  • 0
  • -2
  • 0
  • 2
  • -2
  • 0
  • 2015 Q2
  • 197
  • -185
  • 12
  • -11
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2015 Q3
  • 189
  • -176
  • 13
  • -67
  • 0
  • -56
  • -54
  • 0
  • -1
  • 0
  • -55
  • 1
  • -54
  • 2015 Q4
  • 191
  • -175
  • 16
  • -12
  • 0
  • 0
  • 4
  • 0
  • -1
  • 0
  • 4
  • 2
  • 6
  • 2016
  •  
  • 14.0%
  • 11.7%
  • 15.1%
  • 11.5%
  • 5.1%
  • 4.5%
  •  
  • 1.17
  • 1.17
  • 1.50
  •  
  • 26.7
  •  
  • 517.3
  • 14.8
  • 14.8
  • 0.7
  • 0.7
  • 6.5
  • 14.7
  • 1.6
  •  
  • 46.0%
  • 15.9%
  • 55
  • 336
  • 1.1
  • 2016
  •  
  •  
  • 32
  • 82
  • 7
  • 48
  • 169
  •  
  • 12
  • 0
  • 12
  • 166
  • 0
  • 230
  • 0
  • 420
  • 21
  • 610
  •  
  •  
  • 22
  • 92
  • 118
  • 233
  • 65
  • 0
  • 0
  • 298
  • 29
  • 3
  • 280
  • 0
  • 280
  • 610
  • 2016
  • 694
  • -615
  • -44
  • 35
  • 0
  • 35
  • 44
  • 80
  • -26
  • -18
  • 56
  • 2016 Q1
  • 184
  • -166
  • 18
  • -11
  • 0
  • 0
  • 7
  • 0
  • -1
  • 0
  • 6
  • 0
  • 6
  • 2016 Q2
  • 174
  • -153
  • 20
  • -11
  • 0
  • 0
  • 9
  • 0
  • -1
  • 0
  • 9
  • 0
  • 9
  • 2016 Q3
  • 169
  • -148
  • 20
  • -11
  • 0
  • 0
  • 9
  • 0
  • -1
  • 0
  • 8
  • 0
  • 8
  • 2016 Q4
  • 168
  • -147
  • 20
  • -11
  • 0
  • 0
  • 9
  • 0
  • -1
  • 0
  • 8
  • 0
  • 8
  • 2017
  •  
  • 5.3%
  • 5.3%
  • 5.1%
  • 8.5%
  • 2.1%
  • 1.6%
  •  
  • 0.42
  • 0.42
  • 1.25
  •  
  • 32.9
  •  
  • 705.4
  • 47.1
  • 47.1
  • 0.8
  • 0.8
  • 9.7
  • 39.0
  • 2.7
  •  
  • 46.4%
  • 9.0%
  • 48
  • 293
  • 1.6
  • 2017
  •  
  •  
  • 16
  • 75
  • 5
  • 35
  • 131
  •  
  • 9
  • 0
  • 9
  • 191
  • 0
  • 167
  • 0
  • 376
  • 21
  • 528
  •  
  •  
  • 23
  • 171
  • 15
  • 208
  • 42
  • 0
  • 0
  • 251
  • 26
  • 6
  • 245
  • 0
  • 245
  • 528
  • 2017
  • 857
  • -785
  • -55
  • 18
  • -1
  • 17
  • 55
  • 72
  • -2
  • -11
  • 85
  • 2017 Q1
  • 204
  • -185
  • 18
  • -13
  • 0
  • 0
  • 5
  • 0
  • -1
  • 0
  • 4
  • 1
  • 5
  • 2017 Q2
  • 213
  • -196
  • 17
  • -13
  • 0
  • 0
  • 4
  • 0
  • -1
  • 0
  • 3
  • 1
  • 4
  • 2017 Q3
  • 217
  • -196
  • 21
  • -14
  • 0
  • 0
  • 7
  • 0
  • -1
  • 0
  • 6
  • 1
  • 8
  • 2017 Q4
  • 224
  • -208
  • 16
  • -14
  • 0
  • 0
  • 2
  • 0
  • 0
  • 0
  • 2
  • -4
  • -2
  • 2018 E
  • 2018 E
  • 2018 E
  • 2018 Q1 E
  • 2018 Q2 E
  • 2018 Q3 E
  • 2018 Q4 E
  • 2019 E
  • 2019 E
  • 2019 E
  • 2019 Q1 E
  • 2019 Q2 E
  • 2019 Q3 E
  • 2019 Q4 E
  • 2020 E
  • 2020 E
  • 2020 E
  • 2020 Q1 E

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2018-02-19 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.

Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.